ASCO Reading Room | Moving Beyond the 'Skeletal Survey' in Multiple Myeloma
MedPage Today,
In spite of advances in the treatment of multiple myeloma (MM) in frontline and relapse settings, bone involvement remains one…
In spite of advances in the treatment of multiple myeloma (MM) in frontline and relapse settings, bone involvement remains one…
Photo: Jamie Cotten For The Washington Post Via Getty Images The average cost of new cancer drugs approved by the FDA in 2016…
A new study adds to the growing body of evidence that insurance status and high out-of-pocket costs can pose serious financial…
The ban on government price bargaining, justified by supporters on free-market grounds, has been derided by critics as a giant…